How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015

Vaccine

Volumn 36, Issue 4, 2018, Pages 442-452

  Jorgensen, Pernille ^a   Mereckiene, Jolita ^b   Cotter, Suzanne ^b   Johansen, Kari ^c   Tsolova, Svetla ^c   Brown, Caroline ^a  

^a WHO REGIONAL OFFICE FOR EUROPE   (Denmark)

^b HEALTH PROTECTION SURVEILLANCE CENTRE   (Ireland)

^c EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

Immunization programmes; Influenza vaccines; Vaccination coverage

Indexed keywords

INFLUENZA VACCINE;

AGE; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; EUROPEAN UNION; HEALTH CARE PERSONNEL; HIGH INCOME COUNTRY; HUMAN; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MIDDLE INCOME COUNTRY; PRACTICE GUIDELINE; PREGNANCY; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PUBLIC POLICY; SEASONAL INFLUENZA; VACCINATION COVERAGE; EUROPE; FEMALE; HEALTH CARE POLICY; HEALTH SURVEY; HISTORY; IMMUNOLOGY; INFLUENZA; MALE; MEDICAL GEOGRAPHY; SEASON; VACCINATION; WORLD HEALTH ORGANIZATION;

AGE FACTORS; EUROPE; EUROPEAN UNION; FEMALE; GEOGRAPHY, MEDICAL; HEALTH PERSONNEL; HEALTH POLICY; HISTORY, 21ST CENTURY; HUMANS; IMMUNIZATION PROGRAMS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; POPULATION SURVEILLANCE; PREGNANCY; PUBLIC HEALTH SURVEILLANCE; SEASONS; VACCINATION; VACCINATION COVERAGE; WORLD HEALTH ORGANIZATION;

EID: 85046121206     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2017.12.019     Document Type: Article

References (50)

1. World Health Organization. Influenza (Seasonal). Fact sheet no. 211. Geneva, 2014. http://www.who.int/mediacentre/factsheets/fs211/en/ [accessed 4 September 2017].
2. Mølbak, K., Espenhain, L., Nielsen, J., Tersago, K., Bossuyt, N., Denissov, G., et al. Excess mortality among the elderly in European countries, December 2014 to February 2015. Euro Surveill, 2015, 20, 10.2807/1560-7917.ES2015.20.11.21065.
3. Vestergaard, L.S., Nielsen, J., Krause, T.G., Espenhain, L., Tersago, K., Bustos Sierra, N., et al. Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017. Euro Surveill, 2017, 22, 10.2807/1560-7917.ES.2017.22.14.30506.
4. Molinari, N.M., Ortega-Sanchez, I.R., Messonnier, M.L., Thompson, W.W., Wortley, P.M., Weintraub, E., et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25 (2007), 5086–5096, 10.1016/j.vaccine.2007.03.046.
5. Schanzer, D.L., Zheng, H., Gilmore, J., Statistical estimates of absenteeism attributable to seasonal and pandemic influenza from the Canadian Labour Force Survey. BMC Infect Dis, 11, 2011, 90, 10.1186/1471-2334-11-90.
6. Hayward, A.C., Fragaszy, E.B., Bermingham, A., Wang, L., Copas, A., Edmunds, W.J., et al. Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study. Lancet Respir Med 2 (2014), 445–454, 10.1016/S2213-2600(14)70034-7.
7. Paget, W.J., Balderston, C., Casas, I., Donker, G., Edelman, L., Fleming, D., et al. Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project. Eur J Pediatr 169 (2010), 997–1008, 10.1007/s00431-010-1164-0.
8. Baguelin, M.J.M., Miller, E., Edmunds, W.J., Health and economic impact of the seasonal influenza vaccination programme in England. Vaccine 30 (2012), 3459–3462, 10.1016/j.vaccine.2012.03.019.
9. Estabragh, Z.R., Mamas, M.A., The cardiovascular manifestations of influenza: a systematic review. Int J Cardiol 167 (2013), 2397–2403, 10.1016/j.ijcard.2013.01.274.
10. Joseph, C., Togawa, Y., Shindo, N., Bacterial and viral infections associated with influenza. Influenza Other Respir Viruses 7:Suppl. 2 (2013), 105–113, 10.1111/irv.12089.
11. Rothberg, M.B., Haessler, S.D., Brown, R.B., Complications of viral influenza. Am J Med 121 (2008), 258–264, 10.1016/j.amjmed.2007.10.040.
12. World Health Organization, Vaccines against influenza. WHO position paper - November 2012. Weekly Epidemiol Rec 47 (2012), 461–476.
13. Vanhems, P., Voirin, N., Roche, S., et al. Risk of influenza-like illness in an acute health care setting during community influenza epidemics in 2004–2005, 2005–2006, and 2006–2007: a prospective study. Arch Intern Med 171 (2011), 151–157, 10.1001/archinternmed.2010.500.
14. Kuster, S.P., Shah, P.S., Coleman, B.L., Lam, P.P., Tong, A., Wormsbecker, A., et al. Incidence of influenza in healthy adults and healthcare workers: a systematic review and meta-analysis. PLoS One, 6, 2011, e26239, 10.1371/journal.pone.0026239.
15. Eibach, D., Casalegno, J.S., Bouscambert, M., Bénet, T., Regis, C., Comte, B., et al. Routes of transmission during a nosocomial influenza A(H3N2) outbreak among geriatric patients and healthcare workers. J Hosp Infect 86 (2014), 188–193, 10.1016/j.jhin.2013.11.009.
16. World Health Organization. Prevention and control of influenza pandemics and annual epidemics. Geneva; 2003. http://www.who.int/immunization/sage/1_WHA56_19_Prevention_and_control_of_influenza_pandemics.pdf [accessed 7 September 2017].
17. Council of the European Union. Council Recommendation of 22 December 2009 on seasonal influenza vaccination. Brussels; 2009. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2009:348:0071:0072:EN:PDF [accessed 20 August 2017].
18. World Health Organization. Global vaccine action plan to increase vaccine supply. Geneva; 2006. http://www.who.int/csr/resources/publications/influenza/CDS_EPR_GIP_2006_1.pdf?ua=1 [accessed 5 September 2017].
19. McLean, K.A., Goldin, S., Nannei, C., Sparrow, E., Torelli, G., The 2015 global production capacity of seasonal and pandemic influenza vaccine. Vaccine 34 (2016), 5410–5413, 10.1016/j.vaccine.2016.08.019.
20. World Health Organization. Pandemic influenza preparedness framework for the sharing of influenza viruses and access to vaccines and other benefits. Geneva; 2011. http://apps.who.int/gb/pip/pdf_files/pandemic-influenza-preparedness-en.pdf [accessed 6 September 2017].
21. Mereckiene, J., Cotter, S., D'Ancona, F., Giambi, C., Nicoll, A., Lévy-Bruhl, D., et al. Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009. Euro Surveill, 15(44), 2010 pii:19700.
22. European Centre for Disease Prevention and Control. Technical report. Seasonal influenza vaccination in Europe Overview of vaccination recommendations and coverage rates in the EU Member States for the 2012–13 influenza season. http://ecdc.europa.eu/en/publications/Publications/Seasonal-influenza-vaccination-Europe-2012-13.pdf [accessed 5 September 2017].
23. European Centre for Disease Prevention and Control. Technical report. Seasonal influenza vaccination and antiviral use in Europe. Overview of vaccination recommendations and coverage rates in the EU Member States for the 2013–14 and 2014–15 influenza seasons. http://ecdc.europa.eu/en/publications/Publications/Seasonal-influenza-vaccination-antiviral-use-europe.pdf [accessed 5 September 2017].
24. European Commission. Comission staff working document. State of play on implementation of the Council Recommendation of 22 December 2009 on seasonal influenza vaccination (2009/1019/EU) http://ec.europa.eu/health/sites/health/files/vaccination/docs/seasonflu_staffwd2014_en.pdf [accessed 8 September 2017].
25. Vaccine European New Integrated Collaboration Effort (VENICE II Consortium). National Seasonal Influenza Vaccination Survey in Europe, 2007/2008 Influenza season. http://venice.cineca.org/Final_2009_Seasonal_Influenza_Vaccination_Survey_in_Europe_1.0.pdf [accessed 5 September 2017].
26. United Nations. Department of Economic and Social Affairs PD. World Population Prospects: The 2015 Revision, DVD Edition. Secondary World Population Prospects: The 2015 Revision, DVD Edition 2015. https://esa.un.org/unpd/wpp/ [accessed 8 September 2017].
27. The World Bank. GNI per capita ranking, Atlas method https://data.worldbank.org/indicator/NY.GNP.PCAP.CD [accessed, 29 August 2017]. Secondary GNI per capita ranking, Atlas method https://data.worldbank.org/indicator/NY.GNP.PCAP.CD [accessed 29 August 2017].
28. Palache, A., Oriol-Mathieu, V., Fino, M., Xydia-Charmanta, M., Seasonal influenza vaccine dose distribution in 195 countries (2004–2013): little progress in estimated global vaccination coverage. Vaccine 33 (2015), 5598–5605, 10.1016/j.vaccine.2015.08.082.
29. Ministry of Health Care of the Russian Federation. Research Institute of Influenza. Influenza Vaccines. http://www.influenza.spb.ru/en/science_and_society/influenza_vaccines/ [accessed 28 August 2017].
30. World Health Organization, Influenza vaccines. WHO position paper. Weekly Epidemiol Rec 33 (2005), 279–287.
31. Jamieson, D.J., Honein, M.A., Rasmussen, S.A., Williams, J.L., Swerdlow, D.L., Biggerstaff, M.S., et al. H1N1 2009 influenza virus infection during pregnancy in the USA. The Lancet 374 (2009), 451–458, 10.1016/S0140-6736(09)61304-0.
32. Nair, H., Brooks, W.A., Katz, M., Roca, A., Berkley, J.A., Madhi, S.A., et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. The Lancet 378 (2011), 1917–1930, 10.1016/S0140-6736(11)61051-9.
33. Resolution of the Chief State Sanitary Doctor of the Russian Federation of November 18, 2013 “On approval of sanitary-epidemiological rules 3.1.2.3117-13. Prevention of influenza and other acute respiratory viral infections” [in Russian].
34. Monto, A.S., Sullivan, K.M., Acute respiratory illness in the community. Frequency of illness and the agents involved. Epidemiol Infect 110 (1993), 145–160.
35. Reichert, T.A., Sugaya, N., Fedson, D.S., Glezen, W.P., Simonsen, L., Tashiro, M., The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 344 (2001), 889–896, 10.1056/NEJM200103223441204.
36. Hodgson, D., Baguelin, M., van Leeuwen, E., Panovska-Griffiths, J., Ramsay, M., Pebody, R., et al. Effect of mass paediatric influenza vaccination on existing influenza vaccination programmes in England and Wales: a modelling and cost-effectiveness analysis. Lancet Public Health 2 (2017), e74–e81, 10.1016/S2468-2667(16)30044-5.
37. Mertz, D., Kim, T.H., Johnstone, J., Lam, P.-P., Science, M., Kuster, S.P., et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ, 347, 2013, 10.1136/bmj.f5061.
38. Thompson, W.W., Shay, D.K., Weintraub, E., Brammer, L., Cox, N., Anderson, L.J., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289 (2003), 179–186, 10.1001/jama.289.2.179.
39. Paterson, P., Meurice, F., Stanberry, L.R., Glismann, S., Rosenthal, S.L., Larson, H.J., Vaccine hesitancy and healthcare providers. Vaccine 34 (2016), 6700–6706, 10.1016/j.vaccine.2016.10.042.
40. Butler, R., MacDonald, N.E., Diagnosing the determinants of vaccine hesitancy in specific subgroups: the guide to Tailoring Immunization Programmes (TIP). Vaccine 33 (2015), 4176–4179, 10.1016/j.vaccine.2015.04.038.
41. de Francisco, N., Donadel, M., Jit, M., Hutubessy, R., A systematic review of the social and economic burden of influenza in low- and middle-income countries. Vaccine 33 (2015), 6537–6544, 10.1016/j.vaccine.2015.10.066.
42. Ott, J.J., Klein Breteler, J., Tam, J.S., Hutubessy, R.C.W., Jit, M., de Boer, M.R., Influenza vaccines in low and middle income countries. Hum Vaccin Immunother 9 (2013), 1500–1511, 10.4161/hv.24704.
43. Determann, D., de Bekker-Grob, E.W., French, J., Voeten, H.A., Richardus, J.H., Das, E., et al. Future pandemics and vaccination: public opinion and attitudes across three European countries. Vaccine 34 (2016), 803–808, 10.1016/j.vaccine.2015.12.035.
44. Kardas, P., Zasowska, A., Dec, J., Stachurska, M., Reasons for low influenza vaccination coverage: cross-sectional survey in Poland. Croat Med J 52 (2011), 126–133, 10.3325/cmj.2011.52.126.
45. Mereckiene, J., Cotter, S., Nicoll, A., Lopalco, P., Noori, T., Weber, J.T., et al. Seasonal influenza immunisation in Europe. Overview of recommendations and vaccination coverage for three seasons: pre-pandemic (2008/09), pandemic (2009/10) and post-pandemic (2010/11). Euro Surveill, 19, 2014, 10.2807/1560-7917.ES2014.19.16.20780.
46. World Health Organization, Regional Office for Europe. Tailoring Immunization Programmes. http://www.euro.who.int/en/health-topics/communicable-diseases/measles-and-rubella/activities/tailoring-immunization-programmes-to-reach-underserved-groups-the-tip-approach/the-tip-guide-and-related-publications [accessed 28 August 2017].
47. European Centre for Disease Prevention and Control. Influenza vaccination of health care workers - can uptake be improved? ECDC Virtual Academy. https://eva.ecdc.europa.eu/mod/forum/discuss.php?d=400 [accessed 7 September 2017].
48. World Health Organization, Regional Office for Europe. Methods for assessing influenza vaccination coverage in target groups http://www.euro.who.int/__data/assets/pdf_file/0004/317344/Methods-assessing-influenza-vaccination-coverage-target-groups.pdf?ua=1 [accessed 11 September 2017].
49. Zhang, W., Hirve, S., Kieny, M.-P., Seasonal vaccines – Critical path to pandemic influenza response. Vaccine 35 (2017), 851–852, 10.1016/j.vaccine.2016.12.056.
50. Böhmer, M.M., Walter, D., Krause, G., Müters, S., Gößwald, A., Wichmann, O., Determinants of tetanus and seasonal influenza vaccine uptake in adults living in Germany. Human Vaccines 7 (2011), 1317–1325, 10.4161/hv.7.12.18130.